HOKUTO enters into a comprehensive business partnership with the Japanese Society of Clinical Oncology to disseminate medical information

HOKUTO enters into a comprehensive business partnership with the Japanese Society of Clinical Oncology to disseminate medical information
*HOKUTO Co., Ltd.*
Press release: September 10, 2024
**
HOKUTO enters into a comprehensive business partnership with the Japanese Society of Clinical Oncology to disseminate medical information
*~JSMO official account will start operating from September 10th~*

As of August 14, 2024, HOKUTO Co., Ltd. (Shibuya-ku, Tokyo,
Representative Director and Chairman: Hokuto Igarashi, Representative Director and President/Physician: Souta Yamashita, hereinafter referred to as HOKUTO) is a member of the Japanese Society of Clinical Oncology (Tokyo Minato). We have concluded a comprehensive business alliance with the Japanese Society of Clinical Oncology). In line with this, we will begin operating the official account of the Japanese Society of Clinical Oncology from September 10th. Through this account, we plan to distribute information about academic conferences, lecture announcements, guideline introductions, and explanatory articles by specialists.
By collaborating with the same society that drives the development of cancer therapy, especially medical oncology with a focus on cancer drug therapy, we will strive to disseminate more reliable medical information regarding cancer therapy.

– *Background of the partnership*
Until now, HOKUTO has focused on enriching medical information, especially in the oncology field, but now that we have over 100,000 physician members, we have decided to publish more specialized and accurate medical information as an app that can be used in clinical settings. It has become important to do so. On the other hand, the Japanese Society of Clinical Oncology, whose purpose is to develop clinical oncology in Japan, is particularly concerned with
disseminating information to young doctors who will be responsible for future clinical oncology research. We have come to the conclusion of a business partnership.

*Main initiatives planned through the partnership ~Start of operation of JSMO official account from September 10th~*
・Announcement of academic conference-related events such as academic conference information, educational seminars, and public lectures ・Notice of publication and publication of clinical guidelines, handling regulations, etc.
・Introduction of hot topics such as cancer-related papers and conference reports, etc.
JSMO official account

– *Comment from Hironobu Minami, President of the Japanese Society of Clinical Oncology*
The Japanese Society of Clinical Oncology aims to contribute to public welfare by improving cancer medicine, especially drug therapy. Japan’s largest academic society centered on medical oncologists that promotes education, academic research, and information dissemination related to cancer treatment, and trains and certifies cancer drug therapy specialists who can perform cancer treatment across a wide range of organs. We hope that through this comprehensive collaboration, unbiased information on cancer medicine, especially drug therapy, will be useful for your medical treatment. I also hope that more doctors will join us.

– *Comment from Makoto Ueno, Chairman of the Public Relations and External Relations Committee of the Japanese Society of Clinical Oncology*
The Japanese Society of Medical Oncology (JSMO) is very pleased to be able to collaborate with HOKUTO. The HOKUTO app contains a lot of information about cancer, and I think many of our society members have used it for a long time. In the future, the Society hopes to be of use to all HOKUTO users and further contribute to the advancement of cancer treatment by disseminating information on clinical oncology.

– * About the Japanese Society of Clinical Oncology *
The Japanese Society of Clinical Oncology was established in 1993 as the Japanese Society for Clinical Oncology, and officially began its activities as a voluntary organization in 2002 and as the Japanese Society of Clinical Oncology, a specified non-profit organization in 2004.
In 2015, the organization was reorganized as the Japanese Society of Clinical Oncology, a public interest incorporated association, and to this day we have been engaged in a wide range of public interest projects aimed at promoting academic and cancer treatment centered on clinical oncology. Masu. In addition, with the aim of realizing high-quality cancer drug therapy, we are training “cancer drug therapy specialists” who have the knowledge and skills of cancer drug therapy for a wide range of organs.

– *Comment from HOKUTO CEO/Doctor Sota Yamashita*
We are very honored to be able to enter into a comprehensive business partnership with the Japanese Society of Clinical Oncology. Through this partnership, we will strive to provide cutting-edge knowledge and clinical data regarding cancer treatment more widely and more quickly to medical professionals. We will continue to promote various initiatives in order to meet the needs of the medical field and help improve patient outcomes.

– *About HOKUTO, a clinical support app for doctors*
HOKUTO, a clinical support app for doctors, is a clinical support app that allows you to “obtain,” “save,” and “search” medical information in one place. In recent years, medical information has continued to increase at an accelerating pace due to advances in medicine. In order for doctors to practice better medical care, they are required to input the latest medical information, accurately recall and utilize it in the clinical setting, and conduct additional research as necessary. This makes it difficult to collect information efficiently.
HOKUTO, a clinical support app for doctors, enables quick access to evidence-based medical information, reducing the burden on busy doctors of finding the information they need from a huge amount of medical information, and helping patients We aim to contribute to improving outcomes (clinical results from treatment and prevention) for patients.

* Company Profile*
HOKUTO Co., Ltd. is a medical xIT startup whose mission is “For medical professionals around the world who seek better outcomes.” HOKUTO, a hospital job hunting support service for medical students, centered on HOKUTO, a clinical support app that reduces the workload of doctors.
resident” and “HOKUTO Marketing Solutions,” a marketing support service for medical companies.
Representatives: Representative Director and Chairman Hokuto Igarashi / Representative Director and President Souta Yamashita
Address: Expert Office Shibuya 304, 2-10-15 Shibuya, Shibuya-ku, Tokyo

Corporate site: https://corp.hokuto.app/